Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.21.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Assumptions for Stock Option Grants

 

    2021  
Valuation assumptions      
Expected dividend yield     0.0 %
Expected volatility     119.0% 123.0 %
Expected term (years) – simplified method     5.5 6.1
Risk-free interest rate     0.98% 1.12 %

Schedule of Share Option Activity

Stock option activity during the six-month periods ended June, 2021 and 2020 is as follows:

 

    Number of Options     Weighted average exercise price     Weighted average remaining contractual term  
Balance as of January 1, 2020     509,173     $ 1.30       7.4  
Granted     449,926       2.01          
Exercised     (12,000 )     1.94          
Forfeited     (31,731 )     1.66          
Expired     (38,687 )     1.24          
Balance as of June 30, 2020     876,681     $ 1.65       8.4  
                         
Balance as of January 1, 2021     756,383       1.82       8.7  
Granted     1,229,590       4.61          
Additional options to StemoniX option holders    

205,856

     

4.61

         
Options assumed in Merger     55,840       45.95          
Exercised     (29,916 )     1.24          
Forfeited     (34,717 )     2.00          
Expired     (7,000 )     1.39          
Balance as of June 30, 2021     2,176,036     $ 4.80       9.0  
Exercisable as of June 30, 2021     594,199     $ 5.84       7.7  

Schedule of Share Based Compensation Activity

The Company recognized stock-based compensation related to different instruments for the three and six months ended June 30 as follows:

 

    2021     2020     2021     2020  
    For the three months ended June 30,     For the six months ended June 30,  
    2021     2020     2021     2020  
Stock Options
  $ 352     $ 55     $ 718     $ 97  
Shares issued for services     10       6      

10

      36  
Total
  $ 362     $ 61     $ 728     $ 133